7.980SEK+0.89%Mkt Cap: 212.81M SEKP/E: —Last update: 2026-06-01
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses syste…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap212.81M SEK
Enterprise Value184.37M SEK
Revenue (TTM)98.18M SEK
Gross Profit75.38M SEK
Net Income (TTM)-30.82M SEK
Revenue/Share4.355 SEK
Last Price7.980 SEK
Fiscal Year EndApr 2025
MR QuarterJan 2026
Employees35
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.50
EV/Revenue1.88
P/S2.15
P/B1.16
EPS (TTM)-1.66
EPS (Forward)—
52W Range
6.4004% of range43.15
52W High43.15 SEK
52W Low6.400 SEK
Profitability
Gross Margin82.75%
Oper. Margin-43.80%
EBITDA Margin-41.73%
Profit Margin-33.83%
ROE-17.35%
ROA-15.18%
Growth
Revenue Growth-17.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-38.32M SEK
CapEx (TTM)11.89M SEK
FCF Margin-22.06%
FCF Yield-10.18%
Net Debt-26.57M SEK
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity0.03
Current Ratio4.40
Quick Ratio2.70
Book Value/Sh6.844 SEK
Cash/Share1.131 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.26.03M
Float17.85M
Insiders45.46%
Institutions16.33%
Technical
SMA 507.597 (+5.0%)
SMA 20012.43 (-35.8%)
Beta0.36
S&P 52W Chg27.70%
Avg Vol (30d)39.34K
Avg Vol (10d)43.15K
Technical Indicators
RSI (14)54.1
MACD0.0395
MACD Signal-0.0035
MACD Hist.+0.0430
BB Upper8.178 SEK
BB Middle7.628 SEK
BB Lower7.077 SEK
BB Width14.42%
ATR (14)0.4477 SEK
Vol Ratio (20d)1.88x